Early Diagnosis and Prognosis of Hereditary Breast Cancer

Screening for BRCA1 and BRCA2 mutations in breast cancer patients from mexico: the public health perspective
di: Steven A Narod
Pubblicazione: (2009)

Clinical follow up of Mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes
di: Pablo Ruiz-Flores
Pubblicazione: (2005)

International programs for the detection of breast cancer
di: Robert A Smith
Pubblicazione: (2011)

What is the effectiveness of Raman spectroscopy in screening for head and neck cancer?
di: Tripdatabase
Pubblicazione: (2025)

What are the outcomes of androgen deprivation therapy in prostate cancer?
di: Tripdatabase
Pubblicazione: (2026)

Controversies in Screening and Diagnosis of Gestational Diabetes: Cuba’s Position
di: Pilar Hernández-García
Pubblicazione: (2016)

Journal of Immunotherapy and Precision Oncology
Pubblicazione: (2022)

Magnetic Nanoparticles In Targeted Cancer Therapy: A Comprehensive Review
di: Ruturaj V. Sapate*, Indrajeet D. Gonjari, Prathamesh N. Thorat
Pubblicazione: (2026)

What are the guidelines for administering targeted cancer therapies via feeding tubes, including jejunostomy tubes?
di: Tripdatabase
Pubblicazione: (2025)

Frontiers in Oncology
Pubblicazione: (2012)

BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific
di: Laura Cifuentes-C
Pubblicazione: (2019)

Evolving T-Cells to Outsmart Cancer
di: Eka, Ememobong
Pubblicazione: (2025)

Cancer Biology & Medicine
Pubblicazione: (2019)

European Journal of Breast Health
Pubblicazione: (2022)

How can dietary modifications support cancer treatment and improve prognosis?
di: Tripdatabase
Pubblicazione: (2026)

Is tamoxifen effective for treating painful gynecomastia in patients with prostate cancer and hypogonadism?
di: Tripdatabase
Pubblicazione: (2026)

What are the prognostic factors for tongue cancer?
di: Tripdatabase
Pubblicazione: (2026)

Breast Cancer Research
Pubblicazione: (2015)

ATM polymorphisms IVS24-9delT, IVS38-8T>C, and 5557G>A in Mexican women with familial and/or early-onset breast cancer
di: Fabiola del Carmen Calderón-Zúñiga
Pubblicazione: (2014)

NEW ERA IN THE FIGHT AGAINST CANCER. EVOLUTION AND CANCER: PROGRESS IN TUMOUR TREATMENTS
di: Ana Lluch Hernández
Pubblicazione: (2014)

Oncología
Pubblicazione: (2022)

Breast
Pubblicazione: (2020)

Which vitamin supplements are linked to a higher risk of cancer or a worse prognosis for existing cancer?
di: Tripdatabase
Pubblicazione: (2026)

Genetics of breast cancer: Applications to the Mexican population
di: Elad Ziv
Pubblicazione: (2011)

New approaches to the treatment of orphan genetic disorders: Mitigating molecular pathologies using chemicals
di: Renata V. Velho
Pubblicazione: (2015)

Cáncer de mama en México: una prioridad apremiante
di: Felicia Marie Knaul
Pubblicazione: (2009)

Breast Cancer: Targets and Therapy
Pubblicazione: (2010)

The Progressive Integration of AI Software in the Histopathological Diagnosis of Oral Cancers - Figure 2. Incidence of Oral Cancer in Europe. Source: From GLOBOCAN 2022, International Agency for Research on Cancer (https://gco.iarc.fr/en)
di: Cristian Niky Cumpătă, et al.
Pubblicazione: (2025)

Cancer Treatment and Research Communications
Pubblicazione: (2021)

Development and implementation of guidelines for quality assurance in breast cancer screening: The European experience
di: Lawrence von Karsa
Pubblicazione: (2013)

Imaging-based diagnostic algorithm for HSPs with associated white matter abnormalities
di: Bedeir, Ruwan, et al.
Pubblicazione: (2025)

Targeting RAS/MAPK Signaling: MEK Inhibitors as Breakthrough Therapy for NF1-Associated Plexiform Neurofibroma- A Review
di: Martyna Nowak, et al.
Pubblicazione: (2025)

Precision Medical Sciences
Pubblicazione: (2020)

Translational Oncology
Pubblicazione: (2015)

Cáncer hereditario
di: Moura Vicente, Astrid, et al.
Pubblicazione: (2025)

The use of radiotherapy in Hereditary Angioedema Type 1- C1 Inhibitor deficiency
di: María del Pilar Lara de la Rosa
Pubblicazione: (2018)